Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation
Aging · 2023
DOI: 10.18632/aging.205329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Jingyun Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory for Helicobacter pylori and Microbiota and GI Cancer, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou U…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Stomach Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Conserved long non-coding RNAs (lncRNAs) have not thoroughly been studied in many cancers, including gastric cancer (GC). We have identified a novel lncRNA PTCHD4-AS which was highly conserved between humans and mice and naturally downregulated in GC cell lines and tissues. Notably, PTCHD4-AS was found to be transcriptionally induced by DNA damage agents and its upregulation led to cell cycle arrest at the G2/M phase, in parallel, it facilitated the cell apoptosis induced by cisplatin (CDDP) in GC. Mechanistically, PTCHD4-AS directly bound to the DNA mismatch repair protein MSH2-MSH6 dimer, and facilitated the binding of dimer to ATM, thereby promoting the expression of phosphorylated ATM, p53 and p21. Here we conclude that the upregulation of PTCHD4-AS inhibits proliferation and increases CDDP sensitivity of GC cells via binding with MSH2-MSH6 dimer, activating the ATM-p53-p21 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Key Laboratory for Helicobacter pylori and Microbiota and GI Cancer, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
- Academy of Medical Science, Zhengzhou University, Zhengzhou 450000, China.
- Department of Gastroenterology, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
Zitieren
APA
Wang, J., Mi, Y., Sun, X., Xue, X., Zhao, H., Zhang, M., Hu, B., Bukhari, I., & Zheng, P. (2023). Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation. Aging. https://doi.org/10.18632/aging.205329
Vancouver
Wang J, Mi Y, Sun X, Xue X, Zhao H, Zhang M, et al. Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation. Aging. 2023. doi:10.18632/aging.205329
BibTeX
@article{Wang2023,
author = {Wang, Jingyun and Mi, Yang and Sun, Xiangdong and Xue, Xia and Zhao, Huanjie and Zhang, Mengfei and Hu, Baitong and Bukhari, Ihtisham and Zheng, Pengyuan},
title = {Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205329}
}
EUVIMED